Philips (NYSE: PHG) announced today that it received FDA 510(k) clearance for its SmartHeart planning solution.

Please provide your email address to receive an email when new articles are posted on . Among patients who underwent a stress myocardial perfusion PET scan, increasing magnitude of stress myocardial ...

Use of 3-D whole heart myocardial perfusion cardiac magnetic resonance imaging (MRI) accurately predicts the presence of ischemia-producing stenosis as measured by fractional flow reserve (FFR). The ...

The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...

This exciting technique has gained rapid acceptance in routine clinical practice. This technique is similar to a standard SPECT study, except that a number of images (8 or 16) are acquired at each ...

To detect in-stent restenosis among patients with coronary stents, a new study shows the potential for improved diagnostic accuracy by adding computed tomography perfusion imaging to coronary CT ...

Researchers from the Mayo Clinic have reported findings from the preclinical evaluation of a novel cardiac targeting peptide (CTP)-based radiotracer – [68Ga]NOTA-CTP – being developed as a myocardial ...

A new heart scan is faster and has lower radiation exposure than MRI and invasive angiography, according to a study published in Circulation: Cardiovascular Imaging. Researchers compared three ...

The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offsite pharmacy and delivered as a ready-to-use unit dose. The approval was supported by data from ...